# \[e-drug\] EU & Andean Community Trade Agreement: Implications of IP Demands for Public Health

**URL:** <https://talk.edrugplus.org/t/e-drug-eu-andean-community-trade-agreement-implications-of-ip-demands-for-public-health/36128>\
**Category:** e-drug\
**Created:** [September 22, 2011, 8:06am UTC](https://talk.edrugplus.org/t/e-drug-eu-andean-community-trade-agreement-implications-of-ip-demands-for-public-health/36128 "2011-09-22T08:06:21Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Cora\_van\_den\_Bossche](https://avatars.discourse-cdn.com/v4/letter/c/8e8cbc/32.png) [@Cora\_van\_den\_Bossche](https://talk.edrugplus.org/u/Cora_van_den_Bossche)\
**Post date:** [September 22, 2011, 8:06am UTC](https://talk.edrugplus.org/t/e-drug-eu-andean-community-trade-agreement-implications-of-ip-demands-for-public-health/36128/1 "2011-09-22T08:06:21Z")

</div>

E-DRUG: EU & Andean Community Trade Agreement: Implications of IP Demands for Public Health  
-----------------------------------------------------------------------------------

Dear Members,

As the European Union (EU) moves along in its trade negotiations with  
the MERCOSUR and other developing countries, it is important to look  
back on previous negotiations and to take stock on lessons learnt.

The bilateral trade agreement negotiations between the EU and Peru &  
Colombia have concluded and implementation is now pending. Health Action  
International (HAI) Europe, a member of the Latin-American and Caribbean  
-Global Alliance for Access to Medicines, has prepared a briefing paper  
providing an overview of the agreements' history: the initial European  
demands on Intellectual Property; their implications for access to  
medicines; negotiation developments and their final outcomes.

This publication, The European Union & Andean Community Trade  
Agreements, Intellectual Property & Public Health, also considers the  
negotiations' political context with the breaking up of a multiparty  
agreement into bilateral ones, and the potential impact of several  
Intellectual Property provisions on access to medicines in Colombia and  
Peru. This policy paper is available in English and Spanish. As a  
complement, HAI Europe has also developed a Chronology which traces back  
the EU-Andean Community trade agreement since June 2007.

The Policy paper debrief is available at:

EN version-  
[http://haieurope.org/wp-content/uploads/2011/09/Sep-2011-European-Union-](http://haieurope.org/wp-content/uploads/2011/09/Sep-2011-European-Union-)  
Andean-Community-Trade-Agreements-Intellectual-Property-Public-Health1.p  
df

ES version -  
[http://haieurope.org/wp-content/uploads/2011/09/Sep-2011-CAN-UE-Acuerdos](http://haieurope.org/wp-content/uploads/2011/09/Sep-2011-CAN-UE-Acuerdos)  
-Comerciales-Propiedad-Intelectual-y-Salud-P%C3%BAblica-Qu%C3%A9-pas%C3%  
B3.pdf

The Chronology paper is available at:  
[http://haieurope.org/wp-content/uploads/2011/09/HAI-Europe-Chronology-Th](http://haieurope.org/wp-content/uploads/2011/09/HAI-Europe-Chronology-Th)  
e-EU-Andean-Community-trade-agreements-access-to-medicines.pdf

Sophie Bloemen & Cora Van den Bossche  
Health Action International Europe  
Netherlands  
"Cora van den Bossche" \<cora@haieurope.org\>
